Related Experiment Video
Updated: Dec 30, 2025

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus
Takanori Furukawa1,2, Norman van Rhijn1,2, Marcin Fraczek1
1Manchester Fungal Infection Group, Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, CTF Building, 46 Grafton Street, Manchester, M13 9NT, UK.
Abstract:
The frequency of antifungal resistance, particularly to the azole class of ergosterol biosynthetic inhibitors, is a growing global health problem. Survival rates for those infected with resistant isolates are exceptionally low. Beyond modification of the drug target, our understanding of the molecular basis of azole resistance in the fungal pathogen Aspergillus fumigatus is limited. We reasoned that clinically relevant antifungal resistance could derive from transcriptional rewiring, promoting drug resistance without concomitant reductions in pathogenicity. Here we report a genome-wide annotation of transcriptional regulators in A. fumigatus and construction of a library of 484 transcription factor null mutants. We identify 12 regulators that have a demonstrable role in itraconazole susceptibility and show that loss of the negative cofactor 2 complex leads to resistance, not only to the azoles but also the salvage therapeutics amphotericin B and terbinafine without significantly affecting pathogenicity.
Insights
Antifungal resistance in Aspergillus fumigatus is a major threat. Researchers identified key regulators and found that losing the negative cofactor 2 complex confers broad resistance without impacting fungal pathogenicity.
Area of Science:
- Medical Mycology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Antifungal resistance, especially to azoles, is a growing global health concern with low survival rates for infected individuals.
- The molecular mechanisms underlying azole resistance in Aspergillus fumigatus are not fully understood.
- Clinically relevant resistance may arise from transcriptional changes that enhance drug resistance without compromising pathogenicity.
Purpose of the Study:
- To identify transcriptional regulators involved in azole resistance in Aspergillus fumigatus.
- To investigate the role of transcriptional rewiring in conferring antifungal drug resistance.
- To explore novel therapeutic targets for combating resistant fungal infections.
Main Methods:
- Genome-wide annotation of transcriptional regulators in Aspergillus fumigatus.
- Construction and screening of a library of 484 transcription factor null mutants.
- Assessment of susceptibility to itraconazole, amphotericin B, and terbinafine.
Main Results:
- Twelve transcriptional regulators were identified as having a role in itraconazole susceptibility.
- Loss of the negative cofactor 2 complex resulted in resistance to azoles, amphotericin B, and terbinafine.
- This broad resistance phenotype was observed without a significant reduction in fungal pathogenicity.
Conclusions:
- Transcriptional rewiring is a significant mechanism for developing azole resistance in Aspergillus fumigatus.
- The negative cofactor 2 complex is a critical regulator of antifungal drug susceptibility.
- Targeting this complex may offer a strategy to overcome multidrug resistance in fungal pathogens.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Cofactors and Coenzymes
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors and Coenzymes
Factors Affecting Drug Response: Overview
Gene Regulation in Microbial Communities: Quorum Sensing
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

